![cpt code soft tissue mass chest wall cpt code soft tissue mass chest wall](http://cdn.amegroups.cn/journals/pbpc/files/journals/2/articles/4471/public/4471-PB4-R1.png)
Follow-up of lesion/nodule (i.e., after medical suppression therapy).Evaluation of suspected regional nodal metastases in patients with a proven thyroid carcinoma.Personal or family history of thyroid malignancies.Evaluation of abnormalities detected on other imaging examinations (i.e., areas of abnormal uptake seen on radioisotope thyroid examinations).Evaluation of abnormalities in the tissues and/or organs of the head and neck (i.e., palpable masses).Ultrasound of the head and neck will be considered medically reasonable and necessary when used for the following indications: 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r.76536 – Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation – Average fee amount – $110 – $120ħ6604 – Ultrasound, chest (includes mediastinum), real time with image documentationħ6641 – Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed complete average fee amount – $100 – $120ħ6498 Unlisted magnetic resonance procedure (e.g., diagnostic, interventional)ħ6499 Unlisted diagnostic radiographic procedureħ6641 Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed completeħ6642 Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed limitedħ7058 Magnetic resonance imaging, breast, without and/or with contrast material(s) unilateralħ7059 Magnetic resonance imaging, breast, without and/or with contrast material(s) bilateralħ7065 Diagnostic mammography, including computer-aided detection (CAD) when performed unilateralħ7066 Diagnostic mammography, including computer-aided detection (CAD) when performed bilateralħ7067 Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performedĬoverage Indications, Limitations, and/or Medical Necessity.827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r.826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r.ICD-10-CM C79.89 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
![cpt code soft tissue mass chest wall cpt code soft tissue mass chest wall](https://files.medstro.com/image/authenticated/s--aOvNWhOQ--/kwwdkrsc4e0kf0rofvin.png)
Secondary malignant neoplasm of thyroid gland.Secondary malignant neoplasm of soft tissues of pelvis.Secondary malignant neoplasm of soft tissues of neck.Secondary malignant neoplasm of soft tissues of axilla.Secondary malignant neoplasm of soft tissue of back.Secondary malignant neoplasm of pituitary gland.Secondary malignant neoplasm of parotid gland.Secondary malignant neoplasm of lymph nodes from thyroid.Secondary malignant neoplasm of intra-abdominal organs.Secondary malignant neoplasm of chest wall.Secondary malignant neoplasm of blood vessel.Cancer metastatic to soft tissue of pelvis.Cancer metastatic to soft tissue of neck.Cancer metastatic to soft tissue of back.Cancer metastatic to soft tissue of axilla.Cancer metastatic to lymph node from thyroid.Cancer metastatic to intra abdominal organ.Secondary malignant neoplasm of other and unspecified sites secondary neuroendocrine tumors ( C7B.-).Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified ( C25.9).For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. 8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code.Primary malignant neoplasms overlapping site boundaries.In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. The Table of Neoplasms should be used to identify the correct topography code. Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc.An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. All neoplasms are classified in this chapter, whether they are functionally active or not.